These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18032771)

  • 1. The liver X receptor and atherosclerosis.
    Scott J
    N Engl J Med; 2007 Nov; 357(21):2195-7. PubMed ID: 18032771
    [No Abstract]   [Full Text] [Related]  

  • 2. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.
    Bradley MN; Hong C; Chen M; Joseph SB; Wilpitz DC; Wang X; Lusis AJ; Collins A; Hseuh WA; Collins JL; Tangirala RK; Tontonoz P
    J Clin Invest; 2007 Aug; 117(8):2337-46. PubMed ID: 17657314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid x receptor heterodimers in the metabolic syndrome.
    Shulman AI; Mangelsdorf DJ
    N Engl J Med; 2005 Aug; 353(6):604-15. PubMed ID: 16093469
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunology: Oxysterols hold T cells in check.
    Glass CK; Saijo K
    Nature; 2008 Sep; 455(7209):40-1. PubMed ID: 18769427
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver X receptors: Xcreting Xol to combat atherosclerosis.
    Francis GA; Annicotte JS; Auwerx J
    Trends Mol Med; 2002 Oct; 8(10):455-8. PubMed ID: 12383763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in the study of anti-atherosclerosis drugs].
    Guo CB; Li S
    Yao Xue Xue Bao; 2007 Mar; 42(3):231-5. PubMed ID: 17520819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear receptor LXR is a glucose sensor.
    Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
    Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of LXR.
    Michael LF; Schkeryantz JM; Burris TP
    Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia.
    Lagu B; Pio B; Lebedev R; Yang M; Pelton PD
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3497-503. PubMed ID: 17485209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL-C as a new paradigm in atherosclerotic diseases.
    Shilpha S; Bairy KL
    Indian J Physiol Pharmacol; 2008; 52(4):319-26. PubMed ID: 19585750
    [No Abstract]   [Full Text] [Related]  

  • 13. Combating atherosclerosis with LXR alpha and PPAR alpha agonists: is rational multitargeted polypharmacy the future of therapeutics in complex diseases?
    Kino T; Chrousos GP
    Mol Interv; 2004 Oct; 4(5):254-7. PubMed ID: 15471908
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of human low-density lipoprotein receptor as a novel target gene regulated by liver X receptor alpha.
    Ishimoto K; Tachibana K; Sumitomo M; Omote S; Hanano I; Yamasaki D; Watanabe Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Doi T
    FEBS Lett; 2006 Sep; 580(20):4929-33. PubMed ID: 16920108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver X receptor activation and high-density lipoprotein biology: a reversal of fortune?
    Lee CH; Plutzky J
    Circulation; 2006 Jan; 113(1):5-8. PubMed ID: 16391165
    [No Abstract]   [Full Text] [Related]  

  • 16. Nuclear localization of liver X receptor alpha and beta is differentially regulated.
    Prüfer K; Boudreaux J
    J Cell Biochem; 2007 Jan; 100(1):69-85. PubMed ID: 16888799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LXRs: a new class of oxysterol receptors.
    Peet DJ; Janowski BA; Mangelsdorf DJ
    Curr Opin Genet Dev; 1998 Oct; 8(5):571-5. PubMed ID: 9794827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor and farnesoid X receptor as therapeutic targets.
    Rader DJ
    Am J Cardiol; 2007 Dec; 100(11 A):n15-9. PubMed ID: 18047847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroidal and triterpenoidal fungal metabolites as ligands of liver X receptors.
    Ondeyka JG; Jayasuriya H; Herath KB; Guan Z; Schulman M; Collado J; Dombrowski AW; Kwon SS; McCallum C; Sharma N; MacNaul K; Hayes N; Menke JG; Singh SB
    J Antibiot (Tokyo); 2005 Sep; 58(9):559-65. PubMed ID: 16320760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages.
    Szanto A; Benko S; Szatmari I; Balint BL; Furtos I; Rühl R; Molnar S; Csiba L; Garuti R; Calandra S; Larsson H; Diczfalusy U; Nagy L
    Mol Cell Biol; 2004 Sep; 24(18):8154-66. PubMed ID: 15340076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.